Inventor · disambiguated record
Risto Lammintausta
Also filed as: LAMMINTAUSTA RISTO · LAMMINTAUSTA RISTO A · LAMMINTAUSTA RISTO A S · LAMMINTAUSTA RISTO ARVO SAKARI
23 granted patents·5 pending applications·663 citations·filing 1987–2019
96Inventor score
Files withORION YHTYMAE OY8FORENDO PHARMA LTD5HORMOS MEDICAL OY LTD3CYGNUS THERAPEUTIC SYSTEMS2HORMOS MEDICAL CORP2
Top patents by PatentIndex Score
28 records- 0193US5086058AMethod for treating alcoholism with nalmefeneALKO LTD·Filed 1990·Granted Feb 4, 1992·161 cites·4 claims
- 0290US5217718AMethod and device for administering dexmedetomidine transdermallyCYGNUS THERAPEUTIC SYSTEMS·Filed 1991·Granted Jun 8, 1993·113 cites·28 claims
- 0388US6875775B2Triphenylalkene derivatives and their use as selective estrogen receptor modulatorsHORMOS MEDICAL OY LTD·Filed 2003·Granted Apr 5, 2005·31 cites·8 claims
- 0488US6576645B1Triphenylalkene derivatives and their use as selective estrogen receptor modulatorsHORMOS MEDICAL OY LTD·Filed 2000·Granted Jun 10, 2003·35 cites·20 claims
- 0585US5124157AMethod and device for administering dexmedetomidine transdermallyCYGNUS THERAPEUTIC SYSTEMS·Filed 1989·Granted Jun 23, 1992·77 cites·27 claims
- 0683US5571534ADrug formulations for parenteral useORION YHTYMAE OY·Filed 1992·Granted Nov 5, 1996·86 cites·4 claims
- 0770US5972921AUse of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in menHORMOS MEDICAL OY LTD·Filed 1997·Granted Oct 26, 1999·26 cites·8 claims
- 0869US5304569ACompositions and their use in lowering intraocular pressureORION YHTYMAE OY·Filed 1990·Granted Apr 19, 1994·25 cites·5 claims
- 0967US5703109ASelective aromatase inhibiting compoundsORION YHTYMAE OY·Filed 1993·Granted Dec 30, 1997·20 cites·16 claims
- 1065US5091402AUse of substituted imidazolesORION YHTYMAE OY·Filed 1990·Granted Feb 25, 1992·24 cites·4 claims
- 1165US4783477AAnxiolytic compositionFARMOS OY·Filed 1987·Granted Nov 8, 1988·11 cites·3 claims
- 1259US5439928AAromatase inhibiting 4(5)-imidazolesORION YHTYMAE OY·Filed 1993·Granted Aug 8, 1995·7 cites·27 claims
- 1357US5559141ASelective aromatase inhibiting 4(5)-imidazolesORION YHTYMAE OY·Filed 1992·Granted Sep 24, 1996·13 cites·24 claims
- 1453US2008312239A1Methods for the treatment of erectile dysfunction using fispemifeneQUATRX PHARMACEUTICALS COMPANY·Filed 2008·Application pending·0 cites
- 1553US2020060991A1Methods for the treatment of erectile dysfunction using fispemifeneQUATRX PHARMACEUTICALS·Filed 2019·Application pending·0 cites
- 1651US10626140B2Prodrugs of 17β-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Apr 21, 2020·0 cites·12 claims
- 1749US5464628APharmaceutical compositions containing 4-substituted imidazoles to be administered transdermallyORION YHTYMAE OY·Filed 1992·Granted Nov 7, 1995·13 cites·8 claims
- 1848US10500166B2Methods for the treatment of erectile dysfunction using fispemifeneZERBE ROBERT L·Filed 2013·Granted Dec 10, 2019·0 cites·12 claims
- 1945US6316431B1Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodentsHORMORS MEDICAL OY LTD·Filed 1998·Granted Nov 13, 2001·8 cites·11 claims
- 2044US10377791B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydroxysteroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Aug 13, 2019·0 cites·16 claims
- 2143US9850272B2Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-hydroxy-steroid dehydrogenase, type 1FORENDO PHARMA LTD·Filed 2014·Granted Dec 26, 2017·0 cites·20 claims
- 2243US9663549B2Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as inhibitors of 17β-hydroxysteroid dehydrogenaseFORENDO PHARMA LTD·Filed 2014·Granted May 30, 2017·0 cites·24 claims
- 2342US2005187302A1Method for treatment or prevention of osteoporosis in individuals with high bone turnoverHORMOS MEDICAL CORP·Filed 2004·Application pending·0 cites
- 2442US2006293294A1Method for treatment or prevention of androgen deficiencyHORMOS MEDICAL CORP·Filed 2005·Application pending·0 cites
- 2541US2010261729A1Methods for the treatment of erectile dysfunction using fispemifeneQUATRX PHARMACEUTICALS COMPANY·Filed 2010·Application pending·0 cites
- 2636US5434177AImidazoles for the treatment of age-related cognitive disorders and alzheimerORION YHTYMAE OY·Filed 1991·Granted Jul 18, 1995·11 cites·4 claims
- 2733US10413557B2Prodrugs of 17.BETA.-HSD1-inhibitorsFORENDO PHARMA LTD·Filed 2015·Granted Sep 17, 2019·0 cites·12 claims
- 2830US5962495ASelective aromatase inhibiting compoundsRISTO ARVO SAKARI LAMMINTAUSTA·Filed 1997·Granted Oct 5, 1999·2 cites·10 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →